$MRNS Marinus Pharmaceuticals Announces Presentations and Investor Event at American Epilepsy Society 2022 Annual Meeting

on November 30, 2022 News and Tags: , , , with 0 comments
Time:
2:01 PM
Symbol:
MRNS
Source:
Read more

$MRNS Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

on November 18, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
MRNS
Source:
Business Wire
Read more

$MRNS Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

on November 18, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
MRNS
Source:
Read more

$MRNS Marinus Pharmaceuticals Announces Pricing of $60 Million Public Offering

on November 8, 2022 News and Tags: , , , with 0 comments
Time:
9:12 PM
Symbol:
MRNS
Source:
Business Wire
Read more

$MRNS Marinus Pharmaceuticals Announces Proposed Public Offering

on November 7, 2022 News and Tags: , , , with 0 comments
Time:
2:23 PM
Symbol:
MRNS
Source:
Read more

$MRNS Marinus Pharmaceuticals Announces $32.5 Million Revenue Interest Financing Agreement with Sagard Healthcare Partners

on October 31, 2022 News and Tags: , , , with 0 comments
Time:
5:30 AM
Symbol:
MRNS
Source:
Business Wire
Read more

$MRNS Marinus Pharmaceuticals Announces $32.5 Million Revenue Interest Financing Agreement with Sagard Healthcare Partners

on October 31, 2022 News and Tags: , , , with 0 comments
Time:
5:30 AM
Symbol:
MRNS
Source:
Read more

$MRNS Marinus Pharmaceuticals Announces Multiple Presentations at Upcoming Medical Meetings

on October 11, 2022 News and Tags: , , , with 0 comments
Time:
7:30 AM
Symbol:
MRNS
Source:
Business Wire
Read more

$MRNS Marinus Pharmaceuticals Announces Exercise of First Contract Option by the Biomedical Advanced Research and Development Authority (BARDA)

on September 22, 2022 News and Tags: , , , with 0 comments
Time:
7:30 AM
Symbol:
MRNS
Source:
Business Wire
Read more

$MRNS Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

on September 9, 2022 News and Tags: , , , with 0 comments
Time:
4:05 PM
Symbol:
MRNS
Source:
Business Wire
Read more

$MRNS Marinus Pharmaceuticals to Present at Upcoming Investor Conferences

on September 7, 2022 News and Tags: , , , with 0 comments
Time:
7:30 AM
Symbol:
MRNS
Source:
Business Wire
Read more

$MRNS Marinus Pharmaceuticals Announces Closing of Sale of Priority Review Voucher for $110 Million

on August 29, 2022 News and Tags: , , , with 0 comments
Time:
4:01 PM
Symbol:
MRNS
Source:
Business Wire
Read more

$MRNS Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

on August 12, 2022 News and Tags: , , , with 0 comments
Time:
8:00 AM
Symbol:
MRNS
Source:
Business Wire
Read more

$MRNS Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

on July 15, 2022 News and Tags: , , , with 0 comments
Time:
4:05 PM
Symbol:
MRNS
Source:
Business Wire
Read more

$MRNS Marinus Pharmaceuticals Expands Enrollment Criteria to Support Recruitment in Phase 3 RAISE Trial in Refractory Status Epilepticus

on June 8, 2022 News and Tags: , , , with 0 comments
Time:
7:30 AM
Symbol:
MRNS
Source:
Business Wire
Read more

$MRNS Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

on June 3, 2022 News and Tags: , , , with 0 comments
Time:
4:01 PM
Symbol:
MRNS
Source:
Business Wire
Read more

$MRNS Marinus Pharmaceuticals to Present at Upcoming Medical and Investor Conferences

on May 18, 2022 News and Tags: , , , with 0 comments
Time:
9:00 AM
Symbol:
MRNS
Source:
Business Wire
Read more

$MRNS Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

on April 18, 2022 News and Tags: , , , with 0 comments
Time:
4:30 PM
Symbol:
MRNS
Source:
Business Wire News Releases
Read more

$MRNS Marinus Pharmaceuticals Announces Publication in The Lancet Neurology of ZTALMY® (ganaxolone) Phase 3 Marigold Trial Results

on April 14, 2022 News and Tags: , , , with 0 comments
Time:
7:00 AM
Symbol:
MRNS
Source:
Business Wire News Releases
Read more

$MRNS Marinus Pharmaceuticals Announces FDA Approval of ZTALMY® (ganaxolone) for CDKL5 Deficiency Disorder

on March 18, 2022 News and Tags: , , , with 0 comments
Time:
2:29 PM
Symbol:
MRNS
Source:
Business Wire News Releases
Read more